Director, GLP/GCP/GVP Vendor Quality Management

Company: Intellia Therapeutics
Location: Cambridge
Posted on: February 26, 2026

Job Description:

Why Join Intellia? Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done. We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together. How You Will Achieve More: AsDirector Clinical Development Vendor Quality & Governance, you will serve as the lead strategic expert for global oversight of GCP, GLP, and GVP vendors. In this high-impactindividual contributorrole, you will architect theClinical Quality Governanceframework and ensure all external partners maintain rigorous compliance standards. You will act as the primary liaison for regulatory bodies like theFDAandEMA, leadingInspection Readinessfor vendor related topics. Operating with full autonomy, you will transform complex audit metrics into systemic risk mitigation strategies to safeguard the company’s clinical integrity and strategic interests. Responsibilities: Establish and steer the Clinical Quality Governance strategy> Serve as the authoritative Quality representativeon global vendor management committees, aligning quality objectives with corporate goals and long-term business needs. Develop and manage the annual global budgetfor vendor audits and strategic consultant engagements, ensuring optimal resource allocation. Drive high-level quality-to-quality partnershipswith key vendors, fostering strategic alliances that enhance performance and innovation. Direct the GxP vendor lifecycle strategy, from qualification and risk-based selection to the maintenance of the Approved Vendor Listing (AVL) using sophisticated risk assessment frameworks. Oversee the global GxP vendor audit program, ensuring the strategic planning, execution, and reporting of audits are met with the highest standards of integrity and excellence. Lead the negotiation and implementation of Quality Agreements, establishing standards of accountability for all preferred global suppliers. Synthesize complex audit metrics and Key Quality Indicators (KQIs)into actionable insights for senior leadership, driving systemic risk mitigation and global process improvements. Architect cross-GxP mitigation strategiesto address complex vendor-related issues, ensuring seamless remediation across internal and external operations. Accountable for the integrity of the CAPA program, ensuring that root causes are addressed and corrective actions drive permanent effectiveness. Lead the corporate strategy for Inspection Readiness, serving as the primary point of contact and lead spokesperson during regulatory inspections (e.g.,FDA,EMA) involving vendor compliance. Direct or support investigations into critical quality issues, scientific misconduct, or serious breaches (vendor related), providing senior management with strategic solutions and long-term resolution plans Provide executive-level guidanceon quality expectations and GxP standards to internal and external stakeholders, influencing the global compliance culture. About You: Ability to navigate complex organizational structures and influence senior stakeholders and external partners without formal hierarchical authority. Advanced capability to identify, prioritize, and mitigate systemic GxP risks using data-driven frameworks and risk-based decision-making. Deep interpretive knowledge of global FDA, EMA, and ICH guidelines, with the ability to translate complex regulations into actionable corporate standards. Proficiency in distilling intricate quality issues into high-level briefings and presentations for the C-suite and Board of Directors. Expert skills in negotiating Quality Agreements and resolving high-stakes disputes with strategic vendors while maintaining productive partnerships. Ability to design and oversee sophisticated Key Quality Indicators (KQIs) and metrics programs that drive global continuous improvement. A high degree of self-direction and the ability to manage a broad portfolio of global responsibilities independently. Proficiency in managing global audit budgets, forecasting resource needs, and monitoring expenditures for multi-site Clinical Development activities. Experience working with CROs, vendors, and relationship management. Demonstrated strategic planning and execution skills required. Proven ability to design/evolve and /or implement Quality Management Systems in a fit-for-purpose manner enabling effectiveness, flexibility, and adaptability in a dynamic and evolving business model. Current knowledge of industry trends and best practices- for progressive quality management in a regulated environment. Excellent communication skills and a proven track record Influencing/building/promoting a culture of Quality and Excellence. Minimum of 10–12 years of experience within the pharmaceutical, biotechnology, or CRO industry, with a deep focus onGCP, GLP, and GVPquality assurance A Bachelor’s degree in a scientific discipline is required; an advanced degree (M.S., Ph.D., or MBA) is highly preferred. Professional certifications such asRQAP-GCP (Society of Quality Assurance)are a significant advantage. Proven track record of operating at a Director level as a high-impact individual contributor, demonstrating the ability to drive global initiatives and influence executive decision-making without direct reports. Strong knowledge of GCP and GMP vendor quality processes. Extensive experience supportingGCP/GVP and GLP Inspection Readinessand serving as a primary point of contact during major regulatory inspections from theU.S. Food and Drug Administration (FDA)andEuropean Medicines Agency (EMA) for vendor related matters. Mastery of risk-based auditing methodologies and the ability to manage complex, multi-year vendor quality agreements and global audit schedules. Expert ability to synthesize complex data intoKey Quality Indicators (KQIs)and trend reports that inform senior management of systemic risks and operational health. Exceptional interpersonal and negotiation skills, with the professional presence required to represent the Quality organization in high-stakes vendor committees and executive meetings. Prolonged periods of sitting at a desk and working on a computer. LI-SV1 EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law. Applications are accepted on a rolling basis, and will continue to be accepted until the position is filled at which point the position will be taken down. The base salary for this position is expected to range between $213,063.00 - $260,411.00 USD per year. The salary offered is determined based on a range of factors including, but not limited to, relevant education and training, overall related experience, specialized, rare or in-demand skill sets, internal comparators and other business needs. Upon joining Intellia, your salary will be reviewed periodically and additional factors such as time in role and performance will be considered. Intellia may change the published salary range based on company and market factors. Additional compensation includes a performance-based annual cash bonus, a new hire equity grant, and eligibility to be considered for annual equity awards the value of which are determined annually at the Company’s discretion. For more information about Intellia’s benefits, please click here .

Keywords: Intellia Therapeutics, New Bedford , Director, GLP/GCP/GVP Vendor Quality Management, Accounting, Auditing , Cambridge, Massachusetts